Algo version: 0.98b
Beijing Sun-Novo is listed at the SHH Exchange
Beijing Sun-Novo [688621.SS]
SHH Sector: Healthcare Industry:Drug Manufacturers—Specialty & Generic

Is Beijing Sun-Novo stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, Beijing Sun-Novo pays dividends. Last time was Tuesday 9th of July 2024 where the investors holding the stock on Tuesday 9th of July 2024 were paid CNY0.165 per share. Over the last 3 times between 2022 and 2024, Beijing Sun-Novo has paid CNY1.27 with an average of CNY0.42 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Beijing Sun-Novo 10 years ago, but if you had invested on Monday 21st of June 2021 when the price was CNY85.78, you would have made a loss of CNY-43.94 per share or -51.22%

Yes, the average daily trading liquidity for Beijing Sun-Novo is CNY2.35 million. You should therefore be able to get in and out of your positions relatively fast.

Beijing Sun-Novo has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. With a normal cash flow to debt ratio of 0.16, the company's ability to pay off the debt is normal. Beijing Sun-Novo has a very good net profit margin of 20.83% and should have very high tolerances against inflation.

We have calculated the inflation risk for Beijing Sun-Novo to be low [0.3 of 1]

US inflation for August 2024 was 0.19%. Over the last 12 months, the US inflation is 2.59%. The 10-year treasury yield that indicates the future interest level is currently 4.09 and is down -0.37 over the last 30 days.